2025-10-20 - Analysis Report
Okay, here's an analysis of Schrodinger Inc. (SDGR) based on the provided data, formatted in English with simplified numeric summaries and analysis:

## SDGR (Schrodinger Inc.) Analysis

**Company Overview:** Schrodinger Inc. is a company focused on providing computational solutions for drug discovery and materials science.

**1. Performance vs. S&P 500 (VOO)**

*   **SDGR Total Return:** -53.64%
*   **VOO Total Return:** 65.21%
*   **Divergence:**
    *   Current: -118.9% (SDGR underperformed VOO)
    *   Relative Divergence: 1.2 (SDGR is positioned near the bottom of its historical divergence range compared to VOO)

**Analysis:** SDGR has significantly underperformed the S&P 500 over the period measured. The relative divergence suggests this underperformance is near its historical extreme.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha  | Beta   | Cap(B) |
|------------|---------|-------|--------|--------|--------|
| 2020-2022  | -70.0%  | 78.2% | -76.0% | 0.0    | 1.4    |
| 2021-2023  | -57.0%  | 81.0% | -59.0% | -0.0    | 2.6    |
| 2022-2024  | 6.0%   | 81.0% | -14.0% | -0.0    | 1.4    |
| 2023-2025  | -2.0%   | 82.6% | -63.0% | -0.0    | 1.4    |

**Analysis:**

*   The negative CAGRs indicate significant value erosion over the past few years.
*   MDD: The MDD values are very high, indicating substantial downside risk.
*   Alpha: The strongly negative Alpha figures across all periods reveal significant underperformance relative to the benchmark, suggesting the stock has consistently done worse than expected based on market movements.
*   Beta: The Beta values close to 0 suggest that the stock's price movements are not highly correlated with the overall market.
*   Cap(B): The company's market capitalization has varied during the periods, with some fluctuations in its size.

**2. Recent Stock Price Movements**

*   **Current Price:** $19.31
*   **Previous Close:** $20.31
*   **Change:** -4.92% (Significant drop from previous close)
*   **5-day Moving Average:** $19.87
*   **20-day Moving Average:** $19.95
*   **60-day Moving Average:** $19.71

**Analysis:** The stock price is currently below all three moving averages, and the recent drop of almost 5% indicates negative momentum.

**3. Technical Indicators & Outlook**

*   **Market Risk Indicator (MRI):** 0.5 (Low Investment)
*   **RSI:** 48.59 (Neutral)
*   **PPO:** -0.30 (Slightly bearish)
*   **Hybrid Signal:**  "cash_0%_Buy 100% of cash (47 shares - Very Safe - MRI:0.90)" indicates a theoretically very safe investment based on MRI, but this may conflict with other indicators.
*   **Recent Relative Divergence Change (20-day):** -1.7 (Short-term decline)
*   **Expected Return:** -5132.9% (Very negative long-term outlook relative to S&P 500)

**Analysis:** The MRI suggests a low investment recommendation, although the hybrid signal provides conflicting advice. The RSI is neutral, while the PPO and divergence change indicate bearish short-term momentum. The extremely negative expected return is concerning. The significant price drop (change: -4.92%) suggests recent negative news or market sentiment is impacting the stock.

**4. Recent News & Significant Events**

*   **Oct 15, 2025:** Inducement Grants (Typically positive, attracting employees)
*   **Sep 11, 2025:** Evaluating Valuation (Neutral, but implies potential over/under valuation)
*   **Sep 09, 2025:** Potential Rally (Positive analyst outlook, but speculative)
*   **Aug 27, 2025:** Conference Presentation (Neutral, company updates)
*   **Aug 14, 2025:** Discontinuation of SGR-2921 Program (Negative, pipeline setback)

**Analysis:** The news is mixed. The discontinuation of a program is a clear negative, while positive analyst speculation may provide some support.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (1.56 on scale)
*   **Target Price:** $27.00 (Average) - Suggests significant upside potential from the current price.
*   **Recent Rating Changes:** Not specified, indicating no recent major revisions.

**Analysis:** Analysts are generally positive on the stock with a buy rating and a target price well above the current market price.

**5. Recent Earnings Analysis:**

| Date       | EPS   | Revenue  |
|------------|-------|----------|
| 2025-08-06 | -0.59 | $0.05B   |
| 2025-05-07 | -0.82 | $0.06B   |
| 2024-11-12 | -0.52 | $0.04B   |
| 2024-07-31 | -0.74 | $0.05B   |
| 2025-08-06 | -0.74 | $0.05B   |

**Analysis:** The company is consistently reporting losses (negative EPS). Revenue has been relatively stable but low.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-06-30   | $0.05B  | 47.77%        |
| 2025-03-31   | $0.06B  | 52.26%        |
| 2024-12-31   | $0.09B  | 72.61%        |
| 2024-09-30   | $0.04B  | 50.24%        |
| 2024-06-30   | $0.05B  | 66.20%        |

**Capital and Profitability:**

| Quarter      | Equity  | ROE     |
|--------------|---------|---------|
| 2025-06-30   | $0.34B  | -12.59% |
| 2025-03-31   | $0.37B  | -16.01% |
| 2024-12-31   | $0.42B  | -9.54%  |
| 2024-09-30   | $0.45B  | -8.49%  |
| 2024-06-30   | $0.47B  | -11.40% |

**Analysis:**

*   **Revenue:** Revenue has been fluctuating, with a peak in Q4 2024 and generally lower levels in 2025.
*   **Profit Margin:** The profit margins are high, indicating that the company is effective at controlling the cost of goods sold relative to revenue.
*   **Equity:** Equity has been decreasing over the quarters, which could be a sign of financial strain or strategic capital deployment.
*   **ROE:** The negative ROE values indicate that the company is not generating profits from its equity. The declining ROE trend further indicates worsening profitability.

**7. Overall Analysis**

Schrodinger Inc. (SDGR) presents a mixed picture:

*   **Negatives:** Significant underperformance compared to the S&P 500, negative earnings, decreasing equity, and bearish technical indicators. The discontinuation of a key program is concerning.
*   **Positives:** High profit margins, positive analyst ratings with a substantial target price upside.

**Conclusion:**

SDGR appears to be a high-risk, high-reward investment. While analysts see potential and profit margins are high, the company's financial performance and technical indicators raise concerns. The recent price drop and negative long-term expected return suggest caution. Investors should carefully weigh the potential upside against the significant downside risks before considering an investment in SDGR.
